OPKO Health Receivables 2010-2024 | OPK
OPKO Health receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
| OPKO Health Annual Receivables (Millions of US $) |
|
|---|---|
| 2023 | $123 |
| 2022 | $127 |
| 2021 | $260 |
| 2020 | $286 |
| 2019 | $135 |
| 2018 | $144 |
| 2017 | $166 |
| 2016 | $220 |
| 2015 | $194 |
| 2014 | $20 |
| 2013 | $20 |
| 2012 | $21 |
| 2011 | $13 |
| 2010 | $12 |
| 2009 | $9 |
| OPKO Health Quarterly Receivables (Millions of US $) |
|
|---|---|
| 2024-06-30 | $105 |
| 2024-03-31 | $111 |
| 2023-12-31 | $123 |
| 2023-09-30 | $117 |
| 2023-06-30 | $211 |
| 2023-03-31 | $121 |
| 2022-12-31 | $127 |
| 2022-09-30 | $123 |
| 2022-06-30 | $158 |
| 2022-03-31 | $213 |
| 2021-12-31 | $260 |
| 2021-09-30 | $255 |
| 2021-06-30 | $266 |
| 2021-03-31 | $320 |
| 2020-12-31 | $286 |
| 2020-09-30 | $242 |
| 2020-06-30 | $214 |
| 2020-03-31 | $132 |
| 2019-12-31 | $135 |
| 2019-09-30 | $141 |
| 2019-06-30 | $148 |
| 2019-03-31 | $144 |
| 2018-12-31 | $144 |
| 2018-09-30 | $157 |
| 2018-06-30 | $153 |
| 2018-03-31 | $159 |
| 2017-12-31 | $166 |
| 2017-09-30 | $234 |
| 2017-06-30 | $252 |
| 2017-03-31 | $239 |
| 2016-12-31 | $220 |
| 2016-09-30 | $224 |
| 2016-06-30 | $213 |
| 2016-03-31 | $204 |
| 2015-12-31 | $194 |
| 2015-09-30 | $190 |
| 2015-06-30 | $27 |
| 2015-03-31 | $19 |
| 2014-12-31 | $20 |
| 2014-09-30 | $21 |
| 2014-06-30 | $23 |
| 2014-03-31 | $20 |
| 2013-12-31 | $20 |
| 2013-09-30 | $21 |
| 2013-06-30 | $22 |
| 2013-03-31 | $21 |
| 2012-12-31 | $21 |
| 2012-09-30 | $19 |
| 2012-06-30 | $16 |
| 2012-03-31 | $16 |
| 2011-12-31 | $13 |
| 2011-09-30 | $13 |
| 2011-06-30 | $16 |
| 2011-03-31 | $14 |
| 2010-12-31 | $12 |
| 2010-09-30 | $13 |
| 2010-06-30 | $12 |
| 2010-03-31 | $12 |
| 2009-12-31 | $9 |
| 2009-09-30 | $1 |
| 2009-06-30 | $2 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.092B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.277B | 25.29 |
| Intuitive Surgical (ISRG) | United States | $191.158B | 99.94 |
| Alcon (ALC) | Switzerland | $43.154B | 28.88 |
| Edwards Lifesciences (EW) | United States | $39.233B | 24.91 |
| IQVIA Holdings (IQV) | United States | $38.389B | 21.15 |
| IDEXX Laboratories (IDXX) | United States | $35.196B | 41.45 |
| DexCom (DXCM) | United States | $28.330B | 42.67 |
| Waters (WAT) | United States | $22.897B | 33.86 |
| STERIS (STE) | Ireland | $21.940B | 25.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.323B | 0.00 |
| Hologic (HOLX) | United States | $18.391B | 19.41 |
| Sysmex ADR (SSMXY) | Japan | $12.594B | 39.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.359B | 12.69 |
| Globus Medical (GMED) | United States | $11.177B | 28.46 |
| Penumbra (PEN) | United States | $9.059B | 88.74 |
| Teleflex (TFX) | United States | $9.009B | 14.37 |
| Masimo (MASI) | United States | $8.656B | 41.89 |
| Glaukos (GKOS) | United States | $7.898B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.814B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.614B | 26.15 |
| TransMedics (TMDX) | United States | $3.112B | 98.65 |
| Veracyte (VCYT) | United States | $3.064B | 91.93 |
| Inari Medical (NARI) | United States | $2.972B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.909B | 16.80 |
| Nihon Kohden (NHNKY) | Japan | $2.563B | 19.47 |
| Elekta AB (EKTAY) | Sweden | $2.202B | 17.94 |
| Tandem Diabetes Care (TNDM) | United States | $1.949B | 0.00 |
| RxSight (RXST) | United States | $1.800B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.799B | 9.40 |
| Alphatec Holdings (ATEC) | United States | $1.294B | 0.00 |
| Artivion (AORT) | United States | $1.141B | 75.58 |
| Pulse Biosciences (PLSE) | United States | $1.070B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.896B | 15.23 |
| Paragon 28 (FNA) | United States | $0.862B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.712B | 0.00 |
| IRadimed (IRMD) | United States | $0.703B | 37.98 |
| OrthoPediatrics (KIDS) | United States | $0.587B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.585B | 13.80 |
| AxoGen (AXGN) | United States | $0.552B | 0.00 |
| SiBone (SIBN) | United States | $0.551B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.542B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.493B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.389B | 21.07 |
| Semler Scientific (SMLR) | United States | $0.345B | 23.19 |
| CVRx (CVRX) | United States | $0.345B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.301B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
| NeuroPace (NPCE) | United States | $0.267B | 0.00 |
| Inogen (INGN) | United States | $0.246B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.182B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
| Nevro (NVRO) | United States | $0.167B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.147B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.113B | 16.78 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| 908 Devices (MASS) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.070B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.051B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| Neuronetics (STIM) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |